Profil
Yafit Stark is currently a Director at Omnix Medical Ltd. She was previously a Director at Andromeda Biotech Ltd., PolyPid Ltd., and Chief Clinical Officer at Teva Pharmaceutical Industries Ltd. From 2015 to 2020, she served as an Independent Director at SciSparc Ltd. Dr. Stark holds a doctorate degree from Tel-Aviv University and Weizmann Institute of Science.
Aktive Positionen von Yafit Stark
| Unternehmen | Position | Beginn |
|---|---|---|
Omnix Medical Ltd.
Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotic agents for treatment of infections involving drug-resistant bacteria | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yafit Stark
| Unternehmen | Position | Ende |
|---|---|---|
| SCISPARC LTD. | Direktor/Vorstandsmitglied | 21.08.2020 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Andromeda Biotech Ltd.
Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Develops treatment for autoimmune diabetes | Direktor/Vorstandsmitglied | - |
| POLYPID LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yafit Stark
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Andromeda Biotech Ltd.
Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Develops treatment for autoimmune diabetes | Health Technology |
SciSparc Ltd.
SciSparc Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative vaccines and immunotherapy products | Health Technology |
PolyPid Ltd.
PolyPid Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage specialty pharmaceutical company that is engaged in developing of product candidates based on polymer-lipid encapsulation matrix technology | Health Technology |
Omnix Medical Ltd.
Omnix Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotic agents for treatment of infections involving drug-resistant bacteria | Health Technology |
















